A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.
Swaney, J S
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. [electronic resource] - British journal of pharmacology Aug 2010 - 1699-713 p. digital
Publication Type: Journal Article
1476-5381
10.1111/j.1476-5381.2010.00828.x doi
Administration, Oral
Animals
Bleomycin--pharmacology
Bronchoalveolar Lavage Fluid--chemistry
CHO Cells
Calcium--metabolism
Carbamates--administration & dosage
Cell Line, Tumor
Chemotaxis--drug effects
Collagen--metabolism
Cricetinae
Cricetulus
Disease Models, Animal
Female
Fibroblasts--cytology
Humans
Lung--drug effects
Mice
Mice, Inbred C57BL
Phenylacetates--administration & dosage
Pulmonary Fibrosis--drug therapy
Rats
Receptors, Lysophosphatidic Acid--antagonists & inhibitors
Transfection
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. [electronic resource] - British journal of pharmacology Aug 2010 - 1699-713 p. digital
Publication Type: Journal Article
1476-5381
10.1111/j.1476-5381.2010.00828.x doi
Administration, Oral
Animals
Bleomycin--pharmacology
Bronchoalveolar Lavage Fluid--chemistry
CHO Cells
Calcium--metabolism
Carbamates--administration & dosage
Cell Line, Tumor
Chemotaxis--drug effects
Collagen--metabolism
Cricetinae
Cricetulus
Disease Models, Animal
Female
Fibroblasts--cytology
Humans
Lung--drug effects
Mice
Mice, Inbred C57BL
Phenylacetates--administration & dosage
Pulmonary Fibrosis--drug therapy
Rats
Receptors, Lysophosphatidic Acid--antagonists & inhibitors
Transfection